Kristina Burow
10% Owner; Director; Director, 10% Owner · 9 filings · Latest: Jul 1, 2026
Boundless Bio, Inc.
Kardigan, Inc.
Lyell Immunopharma, Inc.
Neumora Therapeutics, Inc.
Scholar Rock Holding Corp
Seaport Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BOLD | Kristina Burow | 10% Owner | Jul 1, 2026 | Sale | $2.49 | 16,000 | $39.8K | 0 | |
BOLD | Kristina Burow | 10% Owner | Jul 1, 2026 | Option Exercise | $1.03 | 16,000 | $16.5K | 16,000 | |
SRRK | Kristina Burow | Director | Jul 1, 2026 | Sale | $53.74 | 3,053 | $164.1K | 114,657 | |
SRRK | Kristina Burow | — | Jul 1, 2026 | Proposed Sale | $54.79 | 3,053 | $167.3K | — | |
KARD | Kristina Burow | Director, 10% Owner | Jun 22, 2026 | Purchase | $16.00 | 1,250,000 | $20.0M | 15,042,035 | |
SPTX | Kristina Burow | 10% Owner | May 4, 2026 | Purchase | $18.00 | 1,100,000 | $19.8M | 6,294,951 | |
SRRK | Kristina Burow | Director | Apr 23, 2026 | Option Exercise | $9.14 | 89,800 | $820.3K | 110,871 | |
LYEL | Kristina Burow | 10% Owner | Mar 6, 2026 | Purchase | $25.61 | 488,090 | $12.5M | 1,426,528 | |
SRRK | Kristina Burow | — | May 29, 2025 | Proposed Sale | $29.66 | 5,400 | $160.2K | — |